- Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
-
Kim Mk
- KMID: 2522737
- Diabetes Metab J.
- 2021 Nov;45(6):968-969.
- doi: 10.4093/dmj.2021.0311
-
- CITED
-
- Close
- SHARE
-
- Close
- Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
-
Han E, Kim HS
- KMID: 2522739
- Diabetes Metab J.
- 2021 Nov;45(6):972-973.
- doi: 10.4093/dmj.2021.0315
-
- CITED
-
- Close
- SHARE
-
- Close
- Fetal Abdominal Obesity Detected At 24 to 28 Weeks of Gestation Persists Until Delivery Despite Management of Gestational Diabetes Mellitus (Diabetes Metab J 2021;45:547-57)
-
Kim KS
- KMID: 2522736
- Diabetes Metab J.
- 2021 Nov;45(6):966-967.
- doi: 10.4093/dmj.2021.0252
-
- CITED
-
- Close
- SHARE
-
- Close
- Fetal Abdominal Obesity Detected at 24 to 28 Weeks of Gestation Persists until Delivery Despite Management of Gestational Diabetes Mellitus (Diabetes Metab J 2021;45:547-57)
-
Kim W, Park SK, Kim YL
- KMID: 2522738
- Diabetes Metab J.
- 2021 Nov;45(6):970-971.
- doi: 10.4093/dmj.2021.0253
-
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Carnitine Orotate Complex in Fatty Liver
-
Yi HS
- KMID: 2522725
- Diabetes Metab J.
- 2021 Nov;45(6):866-867.
- doi: 10.4093/dmj.2021.0272
-
- CITED
-
- Close
- SHARE
-
- Close
- Obesity, Diabetes, and Increased Cancer Progression
-
Kim DS, Scherer PE
- KMID: 2522721
- Diabetes Metab J.
- 2021 Nov;45(6):799-812.
- doi: 10.4093/dmj.2021.0077
Rates of obesity and diabetes have increased significantly over the past decades and the prevalence is expected to continue to rise further in the coming years. Many observations suggest that... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Body Fat Distribution in Coronary Artery Calcification Progression in Korean Population
-
Lee H, Park HE, Yoon JW, Choi SY
- KMID: 2522740
- Diabetes Metab J.
- 2021 Nov;45(6):974-974.
- doi: 10.4093/dmj.2021.0304
-
- CITED
-
- Close
- SHARE
-
- Close
- Increased Visit-to-Visit Liver Enzyme Variability Is Associated with Incident Diabetes: A Community-Based 12-Year Prospective Cohort Study
-
Bang K, Jun JE, Jeong IK, Ahn KJ, Chung HY, Hwang YC
- KMID: 2522728
- Diabetes Metab J.
- 2021 Nov;45(6):890-898.
- doi: 10.4093/dmj.2020.0208
Background: Fatty liver and/or increased liver enzyme values have been reported to be associated with incident diabetes. We sought to determine whether increased visit-to-visit liver enzyme variability is associated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
-
Moon SJ, Jung I, Park CY
- KMID: 2522722
- Diabetes Metab J.
- 2021 Nov;45(6):813-839.
- doi: 10.4093/dmj.2021.0177
Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely injection to... -
- CITED
-
- Close
- SHARE
-
- Close
- Mitochondrial TFAM as a Signaling Regulator between Cellular Organelles: A Perspective on Metabolic Diseases
-
Koh JH, Kim YW, Seo DY, Sohn TS
- KMID: 2522724
- Diabetes Metab J.
- 2021 Nov;45(6):853-865.
- doi: 10.4093/dmj.2021.0138
Tissues actively involved in energy metabolism are more likely to face metabolic challenges from bioenergetic substrates and are susceptible to mitochondrial dysfunction, leading to metabolic diseases. The mitochondria receive signals... -
- CITED
-
- Close
- SHARE
-
- Close
- Brown Fat as a Regulator of Systemic Metabolism beyond Thermogenesis
-
Yuko OO, Saito M
- KMID: 2522723
- Diabetes Metab J.
- 2021 Nov;45(6):840-852.
- doi: 10.4093/dmj.2020.0291
Brown adipose tissue (BAT) is a specialized tissue for nonshivering thermogenesis to dissipate energy as heat. Although BAT research has long been limited mostly in small rodents, the rediscovery of... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
-
Yoo SJ, Chang SA, Sohn TS, Kwon HS, Lee JM, Moon S, Proot P, Paldánius PM, Yoon KH
- KMID: 2522734
- Diabetes Metab J.
- 2021 Nov;45(6):954-959.
- doi: 10.4093/dmj.2020.0173
We assessed the glycaemic durability with early combination (EC; vildagliptin+metformin [MET], n=22) versus MET monotherapy (n=17), among newly-diagnosed type 2 diabetes mellitus (T2DM) enrolled (between 2012 and 2014) in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-Term Effects of the Internet-Based Korea Diabetes Prevention Study: 6-Month Results of a Community-Based Randomized Controlled Trial
-
Lee JH, Lim SY, Cha SA, Han CJ, Jung AR, Kim KR, Yoon KH, Ko SH
- KMID: 2522735
- Diabetes Metab J.
- 2021 Nov;45(6):960-965.
- doi: 10.4093/dmj.2020.0225
The aims of this study were to determine the short-term effectiveness of an internet-based lifestyle modification (LSM) program in preventing the onset of type 2 diabetes mellitus (T2DM) in prediabetes... -
- CITED
-
- Close
- SHARE
-
- Close
- Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway
-
Hong JH, Lee MK
- KMID: 2522732
- Diabetes Metab J.
- 2021 Nov;45(6):933-947.
- doi: 10.4093/dmj.2020.0223
Background: Carnitine orotate complex (Godex) has been shown to decrease glycated hemoglobin levels and improve steatosis in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease. However, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
-
Kim HS, Lee J, Jung CH, Park JY, Lee WJ
- KMID: 2522733
- Diabetes Metab J.
- 2021 Nov;45(6):948-953.
- doi: 10.4093/dmj.2020.0180
Dulaglutide, a weekly injectable glucagon-like peptide-1 receptor agonist, has demonstrated effectiveness when combined with basal insulin. We examined whether the efficacy of dulaglutide is comparable to that of prandial insulin... -
- CITED
-
- Close
- SHARE
-
- Close
- Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
-
Kong L, Wang H, Li C, Cheng H, Cui Y, Liu L, Zhao Y
- KMID: 2522730
- Diabetes Metab J.
- 2021 Nov;45(6):909-920.
- doi: 10.4093/dmj.2020.0168
Background: The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown... -
- CITED
-
- Close
- SHARE
-
- Close
- The rs2304256 Polymorphism in TYK2 Gene Is Associated with Protection for Type 1 Diabetes Mellitus
-
Pellenz FM, Dieter C, Duarte GCK, Canani LH, de Souza BM, Crispim D
- KMID: 2522729
- Diabetes Metab J.
- 2021 Nov;45(6):899-908.
- doi: 10.4093/dmj.2020.0194
Background: Tyrosine kinase 2 (TYK2) is a candidate gene for type 1 diabetes mellitus (T1DM) since it plays an important role in regulating apoptotic and pro-inflammatory pathways in pancreatic β-cells... -
- CITED
-
- Close
- SHARE
-
- Close
- Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
-
Huang HX, Shen LL, Huang HY, Zhao LH, Xu F, Zhang DM, Zhang XL, Chen T, Wang XQ, Xie Y, Su JB
- KMID: 2522726
- Diabetes Metab J.
- 2021 Nov;45(6):868-879.
- doi: 10.4093/dmj.2020.0149
Background: Type 2 diabetes mellitus (T2DM) is characterized by elevated fasting glucagon and impaired suppression of postprandial glucagon secretion, which may participate in diabetic complications. Therefore, we investigated the associations... -
- CITED
-
- Close
- SHARE
-
- Close
- Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
-
Lee JY, Lee M, Lee JY, Bae J, Shin E, Lee Yh, Lee BW, Kang ES, Cha BS
- KMID: 2522731
- Diabetes Metab J.
- 2021 Nov;45(6):921-932.
- doi: 10.4093/dmj.2020.0187
Background: Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs that exhibit multiple extraglycemic effects. However, there are conflicting results regarding the effects of SGLT2 inhibition on... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018
-
Chae J, Seo MY, Kim SH, Park MJ
- KMID: 2522727
- Diabetes Metab J.
- 2021 Nov;45(6):880-889.
- doi: 10.4093/dmj.2020.0185
Background: There is a lack of recent research on the changes in risk factors for metabolic syndrome (MetS) in the Asian pediatric population. We aimed to determine the 12-year trends... -
- CITED
-
- Close
- SHARE
-
- Close
